web drugs for dysrhythmias

Upload: shellann28

Post on 06-Apr-2018

221 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/3/2019 Web Drugs for Dysrhythmias

    1/25

    Drugs for Dysrhythmias

    Chapter 26

  • 8/3/2019 Web Drugs for Dysrhythmias

    2/25

    Dysrhythmias

    What is a dysrhythmia?

    Why is dysrhythmia a better term than the previously usedarrhythmia?

    Describe the range of symptoms associated withdysrhythmias.

    Discuss the typical symptoms.

    Identify the underlying cause of the symptoms.

  • 8/3/2019 Web Drugs for Dysrhythmias

    3/25

    Dysrhythmias

    Why is it essential to terminate/control

    dysrhythmias?

    What is the most common dysrhythmia?

    Why are ventricular dysrhythmias generallymore serious?

  • 8/3/2019 Web Drugs for Dysrhythmias

    4/25

    Dysrhythmias

    Most often classified by type of rhythmabnormality and location where it is produced.

    Mary has a regular heart beat of 54 beats perminute. Her telemetry monitor shows a normalcomplex configuration. How would thisdysrhythmia be classified?

    Why is correct diagnosis important?

  • 8/3/2019 Web Drugs for Dysrhythmias

    5/25

    Associated Disorders

    Heart disease

    Myocardial infarction

    Hypertension

    Cardiac valve disease

    e.g., mitral stenosis

    CAD

    Medications

    e.g., digoxin

    Hypokalemia

    Stroke

    Diabetes mellitus

    Heart Failure

  • 8/3/2019 Web Drugs for Dysrhythmias

    6/25

    Impulse Conduction

    What is the importance of the action potential?

    What is the purpose of the conduction system?

    How long does it take an impulse to travel ?

    Discuss synchronization.

  • 8/3/2019 Web Drugs for Dysrhythmias

    7/25

    Conduction Abnormalities

    Mary tells the nurse she feels like her heartskips a beat ever so often. Two nursescheck the apical pulse against the radial pulse

    and find a difference of 4 beats per minute.The telemetry monitor occasionally has acomplex that looks different from the rest.

    What is this difference in pulses called?

    What is the reason for the difference?

  • 8/3/2019 Web Drugs for Dysrhythmias

    8/25

  • 8/3/2019 Web Drugs for Dysrhythmias

    9/25

    Nonpharmacologic Interventions

    Cardioversion

    Difibrillation

    Catheter ablation

    Implanted pacemaker

    Implanted cardioverter defibrillator

  • 8/3/2019 Web Drugs for Dysrhythmias

    10/25

    Antidysrhythmic Pharmacotherapy

    Goals

    Terminate existing dysrhythmias

    Prevention of abnormal rhythms

    Guiding principle

    Pharmacotherapy should generally be used for

    patients with overt symptoms or conditions not

    controlled by other means

  • 8/3/2019 Web Drugs for Dysrhythmias

    11/25

    Action Potentials

    AP is initiated when cell membrane Na++

    channels open andN

    a++ rushes into the cell

    rapid depolarization. Ca++ enters the cell

    through Ca++ channels and the influx of Ca++

    triggers release of intracellular Ca++ a lot of

    Ca++ available for myocardial musclecontraction.

  • 8/3/2019 Web Drugs for Dysrhythmias

    12/25

    Action Potentials

    During depolarization inside of plasmamembrane becomes positively charged. Na/Kpump is activated and Na++ is moved out ofcell and K+ is moved back in throughrespective channels.

    How is this process important to cardiacpharmacology?

  • 8/3/2019 Web Drugs for Dysrhythmias

    13/25

    Antidysrhythmics

    Mechanism ofAction

    Alter specific electrophysiologic properties of the

    heart

    Accomplished by:

    Blocking flow through ion channels

    Altering autonomic activity

  • 8/3/2019 Web Drugs for Dysrhythmias

    14/25

    Antidysrhythmic Classifications

    Class I: Na++ Channel Blockers

    Class II: Beta-Adrenergic Blockers

    Class III: K+ Channel Blockers

    Class IV: Ca++ Channel Blockers

    Class V: Miscellaneous

  • 8/3/2019 Web Drugs for Dysrhythmias

    15/25

    Sodium Channel Blockers

    Prototype: procainamide (Pronestyl) p. 368

    3 subclasses based on differences in MOA

    Prevents depolarization

    slowed impulseconduction and suppresses ectopic foci

    Similar to anesthetic agents

    Side effects vary by drug

    What side effects would you expect?

  • 8/3/2019 Web Drugs for Dysrhythmias

    16/25

    Sodium Channel Blockers

    Quinidine and procainamide effective formany dysrhythmias

    Other drugs in class reserved for life-

    threatening dysrhythmias

    Lidocaine can cause CNS toxicity.

    What signs would indicate this?

    Some drugs in class also exert ananticholinergic effect.

    What signs would indicate this?

  • 8/3/2019 Web Drugs for Dysrhythmias

    17/25

    NCs: Sodium Channel Blockers

    Complete health hx and physical exam

    Baseline: ECG, VS, LFTs, RFTs, e-lytes

    Contraindications: HF, BP, MG, Renal or

    Hepatic impairment Drug-Drug interactions

    Monitor ECG

    Frequent BP

    Monitor for change in LOC, respiratory status

    Drug plasma levels

    Quinidine assess for diarrhea

  • 8/3/2019 Web Drugs for Dysrhythmias

    18/25

    Client Teaching: Sodium Channel

    Blockers

    Do not skip dose

    Do not double up if a dose is missed

    No alcohol, caffeine, tobacco

    Keep all scheduled lab appts

    Immediately report:

    SOB, signs of bleeding, excessive bruising, fever,nausea, persistent headache, vision changes,hearing changes, diarrhea, dizziness

  • 8/3/2019 Web Drugs for Dysrhythmias

    19/25

    Beta-Adrenergic Blockers

    Widely used

    Decrease HR and conduction velocity suppression of many dysrhythmias

    Approved: acebutolol, esmolol, propranolol

    Avoid-

    heart block, asthma, severe bradycardia,

    Side effects: Bradycardia, hypotension, dizziness, syncope

    Non-selective beta blockers can cause bronchospasm

  • 8/3/2019 Web Drugs for Dysrhythmias

    20/25

    Potassium Channel Blockers

    Prolong duration of action potential and reduceautomaticity

    Delay repolarization and lengthen refractory

    period stabilization of dysrhythmia Prototype: amiodarone (Cordarone) p. 372

    Limited use due to side effects

    Serious bradycardia and hypotension

    Can worsen dysrhythmias

    Elderly with HF at increase risk of adverse cardiaceffects

  • 8/3/2019 Web Drugs for Dysrhythmias

    21/25

    NCs: Potassium Channel Blockers

    Use cautiously in heart block

    Baseline ECG and VS

    Amiodarone: baseline CXR, PFTs

    IV RX: continuous VS and ECG monitoring Withhold if pulse < 60, SBP < 90

    Watch for s/s of HF

    Monitor serum levels

    Pregnancy category C or D

    Not recommended during lactation

  • 8/3/2019 Web Drugs for Dysrhythmias

    22/25

    Client Teaching: Potassium Channel

    Blockers

    Regular eye exams

    Avoid prolonged sun exposure

    Use sunscreen

    Take with food

    Immediately report:

    SOB, palpitations, cough, vision changes, yellowsclera, jaundice, RUQ pain, dizziness

  • 8/3/2019 Web Drugs for Dysrhythmias

    23/25

  • 8/3/2019 Web Drugs for Dysrhythmias

    24/25

    Calcium Channel Blockers

    Widely prescribed for cardiovascular disorders

    Decrease conduction velocity stabilization of

    dysrhythmia

    Prototype: verapamil (Calan) p. 373

    Dilatizem (Cardizem) and verapamil block calcium

    channels in both heart and arterioles

    Only effective on supraventricular dysrhtymias

    Safe and well tolerated

    Common side effects: bradycardia and hypotension

    Increase risk of bradycardia and HP when concurrent with

    betablockers

  • 8/3/2019 Web Drugs for Dysrhythmias

    25/25

    Miscellaneous Drugs

    Digoxin indicated for atrial fibrillation

    Monitor closely for toxicity

    Adenosine (Adenocard)

    Only used for Paroxysmal SupraventricularTachycardia

    Naturally occurring nucleoside

    Slows impulse conduction throughA

    -V node anddecreases automaticity

    Dyspnea common but self-limiting